Nwam LLC Raises Stock Position in ARK Genomic Revolution ETF $ARKG

Nwam LLC lifted its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 55.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,704 shares of the company’s stock after acquiring an additional 11,294 shares during the quarter. Nwam LLC’s holdings in ARK Genomic Revolution ETF were worth $1,333,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. PNC Financial Services Group Inc. boosted its holdings in shares of ARK Genomic Revolution ETF by 53.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock valued at $29,000 after purchasing an additional 378 shares during the period. Rockefeller Capital Management L.P. increased its holdings in ARK Genomic Revolution ETF by 1.9% during the 4th quarter. Rockefeller Capital Management L.P. now owns 24,243 shares of the company’s stock worth $702,000 after purchasing an additional 461 shares during the period. FWL Investment Management LLC increased its holdings in ARK Genomic Revolution ETF by 17.1% during the 3rd quarter. FWL Investment Management LLC now owns 3,239 shares of the company’s stock worth $90,000 after purchasing an additional 474 shares during the period. Summit Investment Advisory Services LLC increased its holdings in ARK Genomic Revolution ETF by 5.6% during the 1st quarter. Summit Investment Advisory Services LLC now owns 9,270 shares of the company’s stock worth $245,000 after purchasing an additional 495 shares during the period. Finally, StoneX Group Inc. raised its position in ARK Genomic Revolution ETF by 6.5% during the 4th quarter. StoneX Group Inc. now owns 8,746 shares of the company’s stock valued at $253,000 after purchasing an additional 530 shares in the last quarter.

ARK Genomic Revolution ETF Trading Up 0.7%

Shares of ARKG stock opened at $47.15 on Thursday. ARK Genomic Revolution ETF has a twelve month low of $24.20 and a twelve month high of $50.53. The stock has a fifty day simple moving average of $42.77 and a two-hundred day simple moving average of $34.52.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.